The board of directors of Bayer CropScience, which met today, approved a proposal for the planned cessation of manufacture of products of both the company and Bayer Healthcare at Thane in the course of 2007.This was announced in a release issued by Bayer CropScience to the BSE today."This is a strategic decision to enhance synergies in their respective production activities for the India market. However, it is clarified that the cessation of manufacturing and related activities of the company's and Bayer Healthcare products at Thane is not a closure of the company's undertaking," the release added.